Trials / Completed
CompletedNCT01302171
Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Randomised Controlled Trial to Compare the Effects of G-CSF (Granocyte™) and Autologous Bone Marrow Progenitor Cells on Quality of Life and Left Ventricular Function in Patients With Idiopathic Dilated Cardiomyopathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Barts & The London NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A randomised, double-blind, placebo-controlled trial to evaluate the role of intracoronary injection of progenitor cells compared to placebo injection in patients with Dilated Cardiomyopathy who have been pre-treated with G-CSF (Granocyte™) injections for 5 days, and patients treated with a 5 day course of G-CSF (Granocyte™) injection only compared to placebo injection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | granulocyte colony stimulating factor (GCSF) | 10mcg/kg per day 5 days |
| PROCEDURE | bone marrow mononuclear cells | intra coronary injection of stem cells or placebo |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-12-01
- Completion
- 2013-07-01
- First posted
- 2011-02-24
- Last updated
- 2013-11-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01302171. Inclusion in this directory is not an endorsement.